首页 > 最新文献

BJA open最新文献

英文 中文
Paediatric perioperative hypersensitivity: the performance of the current consensus formula and the effect of uneventful anaesthesia on serum tryptase 儿科围手术期超敏反应:现行共识公式的性能以及无痛麻醉对血清胰蛋白酶的影响
Pub Date : 2024-01-17 DOI: 10.1016/j.bjao.2023.100254
Nils Vlaeminck , Marie-Line van der Poorten , Cecilie Nygaard Madsen , Birgitte Bech Melchiors , Moïse Michel , Constance Gonzalez , Rik Schrijvers , Jessy Elst , Christel Mertens , Vera Saldien , Joana Vitte , Lene H. Garvey , Vito Sabato , Didier G. Ebo

Background

Paired sampling of acute (aST) and basal (bST) serum tryptase has been recommended when investigating patients with a suspected perioperative hypersensitivity (POH) reaction. In the current consensus formula, an aST value exceeding (1.2×bST+2) confirms mast cell activation. The current consensus formula has been validated in adults but not in children.

Methods

We prospectively included 96 children who underwent uneventful anaesthesia and sampled serum tryptase at baseline and 60–90 min after induction. Tryptase changes were then compared with those in 94 children with suspected POH who were retrospectively included from four reference centres in Belgium, France, and Denmark.

Results

We observed a median decrease in serum tryptase during uneventful anaesthesia of 0.41 μg L−1 (–15.9%; P<0.001). The current consensus formula identified mast cell activation in 31.9% of paediatric POH patients. After generating receiver operating characteristic curves through 100 repeated five-fold cross-validation, aST>bST+0.71 was identified as the optimal cut-off point to identify mast cell activation. This new paediatric formula has higher sensitivity than the current consensus formula (53.2% vs 31.9%, P<0.001) with a specificity of 96.9%. Analysis in the subpopulation where a culprit was identified and in grade 3–4 reactions similarly yielded higher sensitivity for the new paediatric formula when compared with the current consensus formula (85.3% vs 61.8%; P=0.008 and 78.0% vs 48.8%; P<0.001, respectively). Internally cross-validated sensitivity and specificity were 53.3% and 93.3%, respectively.

Conclusions

This is the first study suggesting the need for an adjusted formula in children to identify perioperative mast cell activation as tryptase is significantly lowered during uneventful anaesthesia. We propose a new formula (aST>bST+0.71) which performs significantly better than the current consensus formula in our multicentric paediatric population.

背景在调查疑似围手术期超敏反应(POH)患者时,建议对急性期(aST)和基础期(bST)血清胰蛋白酶进行配对采样。在当前的共识公式中,aST 值超过 (1.2×bST+2) 即为肥大细胞活化。目前的共识公式已在成人中得到验证,但尚未在儿童中得到验证。方法我们前瞻性地纳入了 96 名接受了平稳麻醉的儿童,并在基线和诱导后 60-90 分钟采集了血清胰蛋白酶样本。然后将胰蛋白酶的变化与比利时、法国和丹麦四个参考中心回顾性纳入的 94 名疑似 POH 患儿的胰蛋白酶变化进行了比较。目前的共识公式确定了31.9%的儿科POH患者存在肥大细胞活化。通过 100 次重复五倍交叉验证生成接收器操作特征曲线后,aST>bST+0.71 被确定为识别肥大细胞活化的最佳临界点。这一新的儿科公式比当前的共识公式具有更高的灵敏度(53.2% vs 31.9%,P<0.001)和 96.9% 的特异性。对已确定元凶的亚人群和 3-4 级反应进行分析后发现,与目前的共识配方相比,新儿科配方的灵敏度同样更高(分别为 85.3% vs 61.8%;P=0.008 和 78.0% vs 48.8%;P<0.001)。结论这是首次有研究表明,由于胰蛋白酶在麻醉过程中会明显降低,因此需要在儿童中使用调整后的公式来识别围术期肥大细胞活化。我们提出了一个新公式(aST>bST+0.71),在我们的多中心儿科人群中,该公式的表现明显优于当前的共识公式。
{"title":"Paediatric perioperative hypersensitivity: the performance of the current consensus formula and the effect of uneventful anaesthesia on serum tryptase","authors":"Nils Vlaeminck ,&nbsp;Marie-Line van der Poorten ,&nbsp;Cecilie Nygaard Madsen ,&nbsp;Birgitte Bech Melchiors ,&nbsp;Moïse Michel ,&nbsp;Constance Gonzalez ,&nbsp;Rik Schrijvers ,&nbsp;Jessy Elst ,&nbsp;Christel Mertens ,&nbsp;Vera Saldien ,&nbsp;Joana Vitte ,&nbsp;Lene H. Garvey ,&nbsp;Vito Sabato ,&nbsp;Didier G. Ebo","doi":"10.1016/j.bjao.2023.100254","DOIUrl":"https://doi.org/10.1016/j.bjao.2023.100254","url":null,"abstract":"<div><h3>Background</h3><p>Paired sampling of acute (aST) and basal (bST) serum tryptase has been recommended when investigating patients with a suspected perioperative hypersensitivity (POH) reaction. In the current consensus formula, an aST value exceeding (1.2×bST+2) confirms mast cell activation. The current consensus formula has been validated in adults but not in children.</p></div><div><h3>Methods</h3><p>We prospectively included 96 children who underwent uneventful anaesthesia and sampled serum tryptase at baseline and 60–90 min after induction. Tryptase changes were then compared with those in 94 children with suspected POH who were retrospectively included from four reference centres in Belgium, France, and Denmark.</p></div><div><h3>Results</h3><p>We observed a median decrease in serum tryptase during uneventful anaesthesia of 0.41 μg L<sup>−1</sup> (–15.9%; <em>P</em>&lt;0.001). The current consensus formula identified mast cell activation in 31.9% of paediatric POH patients. After generating receiver operating characteristic curves through 100 repeated five-fold cross-validation, aST&gt;bST+0.71 was identified as the optimal cut-off point to identify mast cell activation. This new paediatric formula has higher sensitivity than the current consensus formula (53.2% <em>vs</em> 31.9%, <em>P</em>&lt;0.001) with a specificity of 96.9%. Analysis in the subpopulation where a culprit was identified and in grade 3–4 reactions similarly yielded higher sensitivity for the new paediatric formula when compared with the current consensus formula (85.3% <em>vs</em> 61.8%; <em>P</em>=0.008 and 78.0% <em>vs</em> 48.8%; <em>P</em>&lt;0.001, respectively). Internally cross-validated sensitivity and specificity were 53.3% and 93.3%, respectively.</p></div><div><h3>Conclusions</h3><p>This is the first study suggesting the need for an adjusted formula in children to identify perioperative mast cell activation as tryptase is significantly lowered during uneventful anaesthesia. We propose a new formula (aST&gt;bST+0.71) which performs significantly better than the current consensus formula in our multicentric paediatric population.</p></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"9 ","pages":"Article 100254"},"PeriodicalIF":0.0,"publicationDate":"2024-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772609623001338/pdfft?md5=e280cc14797bcb2a4431bdc9972c5ebe&pid=1-s2.0-S2772609623001338-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139480243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Airway management of adult epiglottitis: a systematic review and meta-analysis 成人会厌炎的气道管理:系统回顾与荟萃分析
Pub Date : 2024-01-05 DOI: 10.1016/j.bjao.2023.100250
Anton W.G. Booth , Karla Pungsornruk , Stacey Llewellyn , David Sturgess , Kim Vidhani

Background

Adult epiglottitis is a life-threatening airway emergency where airway protection is the immediate priority. Despite its importance, the optimal approach to airway management remains unclear. We performed a systematic review of the airway management for adult epiglottitis, including meta-analysis of trends over time.

Methods

We systematically searched PubMed, Ovid MEDLINE®, and Embase® for adult epiglottitis studies that described the airway management between 1980 and 2020. The primary outcome was the prevalence of airway intervention. Secondary outcomes were prevalence of tracheal intubation, tracheostomy, and failed intubation. A random-effects model meta-analysis was performed with subgroups defined by decade of study publication. Cases that described the specific method of airway intervention and severity of epiglottitis were included in a separate technique summary.

Results

Fifty-six studies with 10 630 patients were included in the meta-analysis. The overall rate of airway intervention was 15.6% (95% confidence interval [CI] 12.9–18.8%) but the rate decreased from 20% to 10% between 1980 and 2020. The overall rate of tracheal intubation was 10.2% (95% CI 7.1–13.6%) and that of failed intubation was 4.2% (95% CI 1.4–8.0%). The airway technique summary included 128 cases, of which 75 (58.6%) were performed awake and 53 (41.4%) involved general anaesthesia. We identified 32 cases of primary technique failure.

Conclusion

The rate of airway intervention for adult epiglottitis has decreased over four decades to a current level of 10%. Tracheal intubation is a high-risk scenario with a 1 in 25 failure rate. Specific technique selection is most likely influenced by contextual factors including the severity of epiglottitis.

背景成人会厌炎是一种危及生命的气道急症,保护气道是当务之急。尽管会厌炎非常重要,但气道管理的最佳方法仍不明确。我们对成人会厌炎的气道管理进行了系统性回顾,包括随时间变化趋势的荟萃分析。方法我们系统检索了PubMed、Ovid MEDLINE®和Embase®上1980年至2020年间描述成人会厌炎气道管理的研究。主要结果是气道干预的发生率。次要结果是气管插管、气管切开术和插管失败的发生率。采用随机效应模型进行荟萃分析,并根据研究发表的年代进行分组。描述气道干预具体方法和会厌炎严重程度的病例被纳入单独的技术摘要。气道干预的总比例为 15.6%(95% 置信区间 [CI] 12.9-18.8%),但在 1980 年至 2020 年期间,这一比例从 20% 降至 10%。气管插管的总比率为 10.2%(95% 置信区间 [CI] 7.1-13.6%),插管失败的比率为 4.2%(95% 置信区间 [CI] 1.4-8.0%)。气道技术汇总包括 128 例病例,其中 75 例(58.6%)在清醒状态下进行,53 例(41.4%)涉及全身麻醉。结论四十年来,成人会厌炎的气道干预率已下降至目前的 10%。气管插管是一种高风险情况,失败率为 1/25。具体技术的选择很可能受到环境因素的影响,包括会厌炎的严重程度。
{"title":"Airway management of adult epiglottitis: a systematic review and meta-analysis","authors":"Anton W.G. Booth ,&nbsp;Karla Pungsornruk ,&nbsp;Stacey Llewellyn ,&nbsp;David Sturgess ,&nbsp;Kim Vidhani","doi":"10.1016/j.bjao.2023.100250","DOIUrl":"https://doi.org/10.1016/j.bjao.2023.100250","url":null,"abstract":"<div><h3>Background</h3><p>Adult epiglottitis is a life-threatening airway emergency where airway protection is the immediate priority. Despite its importance, the optimal approach to airway management remains unclear. We performed a systematic review of the airway management for adult epiglottitis, including meta-analysis of trends over time.</p></div><div><h3>Methods</h3><p>We systematically searched PubMed, Ovid MEDLINE®, and Embase® for adult epiglottitis studies that described the airway management between 1980 and 2020. The primary outcome was the prevalence of airway intervention. Secondary outcomes were prevalence of tracheal intubation, tracheostomy, and failed intubation. A random-effects model meta-analysis was performed with subgroups defined by decade of study publication. Cases that described the specific method of airway intervention and severity of epiglottitis were included in a separate technique summary.</p></div><div><h3>Results</h3><p>Fifty-six studies with 10 630 patients were included in the meta-analysis. The overall rate of airway intervention was 15.6% (95% confidence interval [CI] 12.9–18.8%) but the rate decreased from 20% to 10% between 1980 and 2020. The overall rate of tracheal intubation was 10.2% (95% CI 7.1–13.6%) and that of failed intubation was 4.2% (95% CI 1.4–8.0%). The airway technique summary included 128 cases, of which 75 (58.6%) were performed awake and 53 (41.4%) involved general anaesthesia. We identified 32 cases of primary technique failure.</p></div><div><h3>Conclusion</h3><p>The rate of airway intervention for adult epiglottitis has decreased over four decades to a current level of 10%. Tracheal intubation is a high-risk scenario with a 1 in 25 failure rate. Specific technique selection is most likely influenced by contextual factors including the severity of epiglottitis.</p></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"9 ","pages":"Article 100250"},"PeriodicalIF":0.0,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772609623001296/pdfft?md5=197b83d667caf002a706f2798aab7e38&pid=1-s2.0-S2772609623001296-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139107471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A randomised controlled trial comparing quality of recovery between desflurane and isoflurane inhalation anaesthesia in patients undergoing ophthalmological surgery at a tertiary hospital in South Africa (DIQoR trial) 比较南非一家三级医院眼科手术患者在地氟醚和异氟醚吸入麻醉下恢复质量的随机对照试验(DIQoR 试验)
Pub Date : 2023-12-20 DOI: 10.1016/j.bjao.2023.100246
Charlé Steyl, Hyla-Louise Kluyts

Background

The patient's experience of their postoperative recovery is an important perioperative outcome, with the 15-item quality of recovery scale (QoR-15) recommended as a standardised outcomes measure. Desflurane has a faster emergence from anaesthesia compared with other volatile anaesthetics, but it is uncertain whether this translates to better subjective quality of recovery. The hypothesis for this study is that patients receiving desflurane for maintenance of anaesthesia would have better postoperative quality of recovery than patients receiving isoflurane.

Methods

Male and female adult patients undergoing ophthalmological surgery under general anaesthesia were randomly allocated to receive desflurane or isoflurane for maintenance of anaesthesia. The primary outcome was to compare postoperative QoR-15 scores. Secondary outcomes included comparing preoperative QoR-15 scores, volatile agent consumption, and time spent in the recovery room.

Results

Data from 164 patients were analysed (80 desflurane, 84 isoflurane). Median (Q1, Q3) postoperative QoR-15 scores were not significantly different (desflurane: 145 [141, 148], isoflurane: 144 [139, 147], 95% confidence interval 0–3, P=0.176, minimal clinically important difference=8). Median (Q1, Q3) volatile agent consumption was 15.4 (12.5, 19.3) ml hr−1 in the desflurane group, and 7.4 (5.9, 9.7) ml hr−1 in the isoflurane group. Median (Q1, Q3) time spent in the recovery room was significantly shorter in the desflurane group (desflurane: 18 [13, 23]; isoflurane: 25 [19, 32], 95% confidence interval −10 to 5, P<0.001).

Conclusions

This study found no difference in quality of recovery between patients who received desflurane or isoflurane for maintenance of general anaesthesia during ophthalmological surgery. A shorter time in the recovery room was not associated with improved QoR-15 scores.

Clinical trial registration

NCT04188314.

背景患者对术后恢复的体验是围手术期的一个重要结果,建议将 15 项恢复质量量表(QoR-15)作为标准化的结果衡量标准。与其他挥发性麻醉药相比,地氟醚能更快地从麻醉中苏醒,但目前还不确定这是否会带来更好的主观恢复质量。本研究的假设是,与接受异氟醚麻醉的患者相比,接受地氟醚维持麻醉的患者术后恢复质量会更好。主要结果是比较术后 QoR-15 评分。次要结果包括比较术前 QoR-15 评分、挥发性药物消耗量和在恢复室所花费的时间。结果 分析了 164 名患者的数据(80 名患者使用地氟醚,84 名患者使用异氟醚)。术后 QoR-15 评分中位数(Q1、Q3)无显著差异(地氟醚:145 [141、148],异氟醚:144 [139、147],95% 置信区间 0-3,P=0.176,最小临床重要性差异=8)。地氟醚组挥发性药物消耗量中位数(第一季度、第三季度)为 15.4(12.5,19.3)毫升/小时-1,异氟醚组为 7.4(5.9,9.7)毫升/小时-1。地氟醚组在恢复室所用时间的中位数(Q1,Q3)明显较短(地氟醚:18 [13,23];异氟醚:25 [19,32],95% 置信区间-10 到 5,P<0.001)。临床试验注册号:NCT04188314。
{"title":"A randomised controlled trial comparing quality of recovery between desflurane and isoflurane inhalation anaesthesia in patients undergoing ophthalmological surgery at a tertiary hospital in South Africa (DIQoR trial)","authors":"Charlé Steyl,&nbsp;Hyla-Louise Kluyts","doi":"10.1016/j.bjao.2023.100246","DOIUrl":"https://doi.org/10.1016/j.bjao.2023.100246","url":null,"abstract":"<div><h3>Background</h3><p>The patient's experience of their postoperative recovery is an important perioperative outcome, with the 15-item quality of recovery scale (QoR-15) recommended as a standardised outcomes measure. Desflurane has a faster emergence from anaesthesia compared with other volatile anaesthetics, but it is uncertain whether this translates to better subjective quality of recovery. The hypothesis for this study is that patients receiving desflurane for maintenance of anaesthesia would have better postoperative quality of recovery than patients receiving isoflurane.</p></div><div><h3>Methods</h3><p>Male and female adult patients undergoing ophthalmological surgery under general anaesthesia were randomly allocated to receive desflurane or isoflurane for maintenance of anaesthesia. The primary outcome was to compare postoperative QoR-15 scores. Secondary outcomes included comparing preoperative QoR-15 scores, volatile agent consumption, and time spent in the recovery room.</p></div><div><h3>Results</h3><p>Data from 164 patients were analysed (80 desflurane, 84 isoflurane). Median (Q1, Q3) postoperative QoR-15 scores were not significantly different (desflurane: 145 [141, 148], isoflurane: 144 [139, 147], 95% confidence interval 0–3, <em>P</em>=0.176, minimal clinically important difference=8). Median (Q1, Q3) volatile agent consumption was 15.4 (12.5, 19.3) ml hr<sup>−1</sup> in the desflurane group, and 7.4 (5.9, 9.7) ml hr<sup>−1</sup> in the isoflurane group. Median (Q1, Q3) time spent in the recovery room was significantly shorter in the desflurane group (desflurane: 18 [13, 23]; isoflurane: 25 [19, 32], 95% confidence interval −10 to 5, <em>P</em>&lt;0.001).</p></div><div><h3>Conclusions</h3><p>This study found no difference in quality of recovery between patients who received desflurane or isoflurane for maintenance of general anaesthesia during ophthalmological surgery. A shorter time in the recovery room was not associated with improved QoR-15 scores.</p></div><div><h3>Clinical trial registration</h3><p>NCT04188314.</p></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"9 ","pages":"Article 100246"},"PeriodicalIF":0.0,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772609623001259/pdfft?md5=6f7fcd5d4c4cfdd7584eeb5ff0b53941&pid=1-s2.0-S2772609623001259-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139033370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ketamine for postoperative avoidance of depressive symptoms: the K-PASS feasibility randomised trial 氯胺酮用于术后避免抑郁症状:K-PASS 可行性随机试验
Pub Date : 2023-12-15 DOI: 10.1016/j.bjao.2023.100245
Bradley A. Fritz , Bethany R. Tellor Pennington , Catherine Dalton , Christine Horan , Ben J.A. Palanca , Julie A. Schweiger , Logan Griffin , Wilberforce Tumwesige , Jon T. Willie , Nuri B. Farber

Background

Surgical patients with previous depression frequently experience postoperative depressive symptoms. This study's objective was to determine the feasibility of a placebo-controlled trial testing the impact of a sustained ketamine infusion on postoperative depressive symptoms.

Methods

This single-centre, triple-blind, placebo-controlled randomised clinical trial included adult patients with depression scheduled for inpatient surgery. After surgery, patients were randomly allocated to receive ketamine (0.5 mg kg−1 over 10 min followed by 0.3 mg kg−1 h−1 for 3 h) or an equal volume of normal saline. Depressive symptoms were measured using the Montgomery–Asberg Depression Rating Scale. On post-infusion day 1, participants guessed which intervention they received. Feasibility endpoints included the fraction of patients approached who were randomised, the fraction of randomised patients who completed the study infusion, and the fraction of scheduled depression assessments that were completed.

Results

In total, 32 patients were allocated a treatment, including 31/101 patients approached after a protocol change (31%, 1.5 patients per week). The study infusion was completed without interruption in 30/32 patients (94%). In each group, 7/16 participants correctly guessed which intervention they received. Depression assessments were completed at 170/192 scheduled time points (89%). Between baseline and post-infusion day 4 (pre-specified time point of interest), median depressive symptoms decreased in both groups, with difference-in-differences of −1.00 point (95% confidence interval −3.23 to 1.73) with ketamine compared with placebo. However, the between-group difference did not persist at other time points.

Conclusions

Patient recruitment, medication administration, and clinical outcome measurement appear to be highly feasible, with blinding maintained. A fully powered trial may be warranted.

Clinical trial registration

NCT05233566.

背景曾患有抑郁症的手术患者经常会出现术后抑郁症状。本研究的目的是确定一项安慰剂对照试验的可行性,测试持续输注氯胺酮对术后抑郁症状的影响。方法这项单中心、三重盲法、安慰剂对照随机临床试验纳入了计划接受住院手术的成年抑郁症患者。手术后,患者被随机分配接受氯胺酮(10 分钟内 0.5 毫克/公斤-1,然后 0.3 毫克/公斤-1 小时-1,持续 3 小时)或等量的生理盐水。抑郁症状采用蒙哥马利-阿斯伯格抑郁量表进行测量。注射后第 1 天,参与者猜测自己接受了哪种干预。可行性终点包括接受随机治疗的患者比例、完成研究输液的随机患者比例以及完成预定抑郁评估的患者比例。结果共有 32 名患者被分配了治疗方案,其中包括在方案变更后接受治疗的 31/101 名患者(31%,每周 1.5 名患者)。有 30/32 名患者(94%)不间断地完成了输液治疗。在每组中,有 7/16 名参与者正确猜出了他们接受的干预措施。在 170/192 个预定时间点完成了抑郁评估(89%)。从基线到输液后第4天(预先指定的相关时间点),两组患者的抑郁症状中位数均有所下降,氯胺酮与安慰剂相比,差异为-1.00点(95%置信区间-3.23至1.73)。结论在保持盲法的前提下,患者招募、用药和临床结果测量似乎非常可行。临床试验注册号:NCT05233566。
{"title":"Ketamine for postoperative avoidance of depressive symptoms: the K-PASS feasibility randomised trial","authors":"Bradley A. Fritz ,&nbsp;Bethany R. Tellor Pennington ,&nbsp;Catherine Dalton ,&nbsp;Christine Horan ,&nbsp;Ben J.A. Palanca ,&nbsp;Julie A. Schweiger ,&nbsp;Logan Griffin ,&nbsp;Wilberforce Tumwesige ,&nbsp;Jon T. Willie ,&nbsp;Nuri B. Farber","doi":"10.1016/j.bjao.2023.100245","DOIUrl":"https://doi.org/10.1016/j.bjao.2023.100245","url":null,"abstract":"<div><h3>Background</h3><p>Surgical patients with previous depression frequently experience postoperative depressive symptoms. This study's objective was to determine the feasibility of a placebo-controlled trial testing the impact of a sustained ketamine infusion on postoperative depressive symptoms.</p></div><div><h3>Methods</h3><p>This single-centre, triple-blind, placebo-controlled randomised clinical trial included adult patients with depression scheduled for inpatient surgery. After surgery, patients were randomly allocated to receive ketamine (0.5 mg kg<sup>−1</sup> over 10 min followed by 0.3 mg kg<sup>−1</sup> h<sup>−1</sup> for 3 h) or an equal volume of normal saline. Depressive symptoms were measured using the Montgomery–Asberg Depression Rating Scale. On post-infusion day 1, participants guessed which intervention they received. Feasibility endpoints included the fraction of patients approached who were randomised, the fraction of randomised patients who completed the study infusion, and the fraction of scheduled depression assessments that were completed.</p></div><div><h3>Results</h3><p>In total, 32 patients were allocated a treatment, including 31/101 patients approached after a protocol change (31%, 1.5 patients per week). The study infusion was completed without interruption in 30/32 patients (94%). In each group, 7/16 participants correctly guessed which intervention they received. Depression assessments were completed at 170/192 scheduled time points (89%). Between baseline and post-infusion day 4 (pre-specified time point of interest), median depressive symptoms decreased in both groups, with difference-in-differences of −1.00 point (95% confidence interval −3.23 to 1.73) with ketamine compared with placebo. However, the between-group difference did not persist at other time points.</p></div><div><h3>Conclusions</h3><p>Patient recruitment, medication administration, and clinical outcome measurement appear to be highly feasible, with blinding maintained. A fully powered trial may be warranted.</p></div><div><h3>Clinical trial registration</h3><p>NCT05233566.</p></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"9 ","pages":"Article 100245"},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772609623001247/pdfft?md5=6eac958aafb846164a0a37ebc896cbff&pid=1-s2.0-S2772609623001247-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138739338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous wound infusion catheter as part of a multimodal analgesia regimen for post-Caesarean delivery pain: a quality improvement impact study 作为剖腹产后疼痛多模式镇痛方案一部分的连续伤口输液导管:质量改进影响研究
Pub Date : 2023-12-14 DOI: 10.1016/j.bjao.2023.100242
Cedar Fowler , Emily Stockert , Dan Hoang , Nan Guo , Edward Riley , Pervez Sultan , Brendan Carvalho

Background

The role of continuous wound infusion catheters as part of a multimodal analgesia strategy after Caesarean delivery is unclear. We introduced continuous wound infusion catheters to our multimodal analgesia regimen to evaluate the impact on analgesic outcomes after Caesarean delivery.

Methods

After institutional review board (IRB) approval, a 4-month practice change was instituted as a quality improvement initiative. In addition to multimodal analgesia, continuous wound infusion catheters for up to 3 days were offered on alternate weeks for all women undergoing Caesarean deliveries. The primary outcome was postoperative in-hospital opioid consumption. Secondary outcomes were static and dynamic pain scores at 24 and 72 h, time until first analgesic request, opioid-related side-effects, length of stay, satisfaction (0–100%), and continuous wound infusion catheter-related complications.

Results

All women scheduled for Caesarean delivery (n=139) in the 4-month period were included in the analysis, with 70 women receiving continuous wound infusion catheters, and 69 in the control group. Opioid consumption (continuous wound infusion catheter group 11.3 [7.5–61.9] mg morphine equivalents vs control group 30.0 [11.3–48.8] mg morphine equivalents), pain scores (except 24 h resting pain scores which were higher in the control group 2 [1–3] vs 1.5 [0–3] in the continous wound infusion catheters group; P=0.05), side-effects, length of stay, and complications were similar between groups. Satisfaction scores at 24 h were higher with continuous wound infusion catheters (100% [91–100%] vs 90% [86–100%]; P=0.003) with no differences at 72 h. One patient demonstrated symptoms of systemic local anaesthetic toxicity which resolved without significant harm.

Conclusions

The addition of continuous wound infusion catheters to a multimodal analgesia regimen for post-Caesarean delivery pain management demonstrated minimal clinically significant analgesic benefits. Future studies are needed to explore the use of continuous wound infusion catheters in populations that may benefit most from this intervention.

背景连续伤口输液导管作为剖腹产后多模式镇痛策略的一部分,其作用尚不明确。我们在多模式镇痛方案中引入了连续伤口输注导管,以评估其对剖腹产后镇痛效果的影响。除多模式镇痛外,还为所有剖腹产产妇隔周提供长达 3 天的连续伤口输液导管。主要结果是术后院内阿片类药物的消耗量。次要结果为24小时和72小时的静态和动态疼痛评分、首次申请镇痛药前的时间、阿片类药物相关副作用、住院时间、满意度(0-100%)以及伤口持续输注导管相关并发症。结果 所有在4个月内计划剖腹产的产妇(n=139)均纳入分析,其中70名产妇接受伤口持续输注导管,69名产妇接受对照组。各组间的阿片类药物消耗量(持续伤口输注导管组为11.3 [7.5-61.9] 毫克吗啡当量,对照组为30.0 [11.3-48.8] 毫克吗啡当量)、疼痛评分(24 小时静息痛评分除外,对照组为2 [1-3] 分,持续伤口输注导管组为1.5 [0-3] 分;P=0.05)、副作用、住院时间和并发症相似。一名患者出现了全身局麻药中毒症状,但症状缓解后并无大碍。结论在剖宫产术后疼痛治疗的多模式镇痛方案中加入连续伤口输注导管的临床镇痛效果甚微。未来的研究需要探索在可能从这种干预措施中获益最多的人群中使用连续伤口输注导管。
{"title":"Continuous wound infusion catheter as part of a multimodal analgesia regimen for post-Caesarean delivery pain: a quality improvement impact study","authors":"Cedar Fowler ,&nbsp;Emily Stockert ,&nbsp;Dan Hoang ,&nbsp;Nan Guo ,&nbsp;Edward Riley ,&nbsp;Pervez Sultan ,&nbsp;Brendan Carvalho","doi":"10.1016/j.bjao.2023.100242","DOIUrl":"https://doi.org/10.1016/j.bjao.2023.100242","url":null,"abstract":"<div><h3>Background</h3><p>The role of continuous wound infusion catheters as part of a multimodal analgesia strategy after Caesarean delivery is unclear. We introduced continuous wound infusion catheters to our multimodal analgesia regimen to evaluate the impact on analgesic outcomes after Caesarean delivery.</p></div><div><h3>Methods</h3><p>After institutional review board (IRB) approval, a 4-month practice change was instituted as a quality improvement initiative. In addition to multimodal analgesia, continuous wound infusion catheters for up to 3 days were offered on alternate weeks for all women undergoing Caesarean deliveries. The primary outcome was postoperative in-hospital opioid consumption. Secondary outcomes were static and dynamic pain scores at 24 and 72 h, time until first analgesic request, opioid-related side-effects, length of stay, satisfaction (0–100%), and continuous wound infusion catheter-related complications.</p></div><div><h3>Results</h3><p>All women scheduled for Caesarean delivery (<em>n</em>=139) in the 4-month period were included in the analysis, with 70 women receiving continuous wound infusion catheters, and 69 in the control group. Opioid consumption (continuous wound infusion catheter group 11.3 [7.5–61.9] mg morphine equivalents <em>vs</em> control group 30.0 [11.3–48.8] mg morphine equivalents), pain scores (except 24 h resting pain scores which were higher in the control group 2 [1–3] <em>vs</em> 1.5 [0–3] in the continous wound infusion catheters group; <em>P</em>=0.05), side-effects, length of stay, and complications were similar between groups. Satisfaction scores at 24 h were higher with continuous wound infusion catheters (100% [91–100%] <em>vs</em> 90% [86–100%]; <em>P</em>=0.003) with no differences at 72 h. One patient demonstrated symptoms of systemic local anaesthetic toxicity which resolved without significant harm.</p></div><div><h3>Conclusions</h3><p>The addition of continuous wound infusion catheters to a multimodal analgesia regimen for post-Caesarean delivery pain management demonstrated minimal clinically significant analgesic benefits. Future studies are needed to explore the use of continuous wound infusion catheters in populations that may benefit most from this intervention.</p></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"9 ","pages":"Article 100242"},"PeriodicalIF":0.0,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772609623001211/pdfft?md5=41a73c7c696ee5a9aa704f384aa8e1a8&pid=1-s2.0-S2772609623001211-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138738648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary perioperative haemodynamic effects of ß-receptor blockade in patients with catecholamine-secreting tumours ß-受体阻断对儿茶酚胺分泌肿瘤患者围手术期血流动力学的影响
Pub Date : 2023-12-01 DOI: 10.1016/j.bjao.2023.100240
Harald Groeben , Bente J. Nottebaum , Aarne Feldheiser , Steffen Buch , Piero F. Alesina , Martin K. Walz

Introduction

Guidelines for the treatment of catecholamine-producing tumours strictly recommend starting ß-receptor blocking medication only after α-receptor blockade has been established. This recommendation is supported only by non-surgical case reports. However, in clinical practice ß-receptor blockade is often started before the diagnosis of a phaeochromocytoma is made. As we routinely treat patients with catecholamine-producing tumours without α-receptor blockade, our aim was to evaluate haemodynamic changes in such patients with and without ß-receptor blockade.

Methods

Perioperative blood pressure was assessed prospectively for all patients. The primary outcome was the highest pre-, intra-, and postoperative systolic blood pressure in patients with or without a ß-receptor blockade. Secondary outcomes were the incidence of intraoperative systolic blood pressure peaks >250 mm Hg and hypotensive episodes. Subsequently, a propensity score matching (PSM) analysis was performed.

Results

Out of 584 phaeochromocytoma and paraganglioma resections, 383 operations were performed without α-receptor blockade (including 84 with ß-receptor blockade). Before operation and intraoperatively, patients with ß-receptor blockade presented with higher systolic blood pressure (155 [25] and 207 [62] mm Hg) than patients without ß-receptor blockade (147 [24] and 183 [52] mm Hg; P=0.006 and P=0.001, respectively). Intraoperatively, patients with ß-receptor blockade demonstrated a higher incidence of hypotensive episodes (25% without vs 41% with ß-blockade; P<0.001). After propensity score matching no difference between the groups could be confirmed.

Conclusion

Overall, patients with isolated ß-receptor blockade developed higher blood pressure before operation and intraoperatively. After propensity score matching a difference could no longer be detected. Overall, ß-receptor blockade seems to be more a sign for severe disease than a risk factor for haemodynamic instability.

导论儿茶酚胺产生性肿瘤的治疗指南严格建议在α受体阻断建立后才开始ß-受体阻断药物治疗。这一建议仅得到非手术病例报告的支持。然而,在临床实践中,ß-受体阻断通常在诊断嗜铬细胞瘤之前就开始了。由于我们常规治疗无α-受体阻断的儿茶酚胺生成肿瘤患者,我们的目的是评估有和没有ß-受体阻断的这类患者的血流动力学变化。方法对所有患者术前血压进行前瞻性评估。主要结局是ß-受体阻断或非ß-受体阻断患者术前、术中和术后收缩压最高。次要结局是术中收缩压峰值(250 mm Hg)和低血压发作的发生率。随后,进行倾向评分匹配(PSM)分析。结果584例嗜铬细胞瘤和副神经节瘤切除术中,未阻断α-受体的手术383例(其中ß-受体阻断84例)。术前和术中ß-受体阻断患者收缩压(155[25]和207 [62]mm Hg)高于未ß-受体阻断患者(147[24]和183 [52]mm Hg);P=0.006和P=0.001)。术中,ß-受体阻断的患者表现出更高的低血压发作发生率(未ß-受体阻断的25% vs ß-受体阻断的41%;术中,0.001)。倾向评分匹配后,组间无差异。结论孤立性ß-受体阻滞剂患者术前及术中血压升高。在倾向评分匹配后,就无法再检测到差异。总的来说,ß-受体阻断似乎更像是严重疾病的征兆,而不是血流动力学不稳定的危险因素。
{"title":"Primary perioperative haemodynamic effects of ß-receptor blockade in patients with catecholamine-secreting tumours","authors":"Harald Groeben ,&nbsp;Bente J. Nottebaum ,&nbsp;Aarne Feldheiser ,&nbsp;Steffen Buch ,&nbsp;Piero F. Alesina ,&nbsp;Martin K. Walz","doi":"10.1016/j.bjao.2023.100240","DOIUrl":"https://doi.org/10.1016/j.bjao.2023.100240","url":null,"abstract":"<div><h3>Introduction</h3><p>Guidelines for the treatment of catecholamine-producing tumours strictly recommend starting ß-receptor blocking medication only after α-receptor blockade has been established. This recommendation is supported only by non-surgical case reports. However, in clinical practice ß-receptor blockade is often started before the diagnosis of a phaeochromocytoma is made. As we routinely treat patients with catecholamine-producing tumours without α-receptor blockade, our aim was to evaluate haemodynamic changes in such patients with and without ß-receptor blockade.</p></div><div><h3>Methods</h3><p>Perioperative blood pressure was assessed prospectively for all patients. The primary outcome was the highest pre-, intra-, and postoperative systolic blood pressure in patients with or without a ß-receptor blockade. Secondary outcomes were the incidence of intraoperative systolic blood pressure peaks &gt;250 mm Hg and hypotensive episodes. Subsequently, a propensity score matching (PSM) analysis was performed.</p></div><div><h3>Results</h3><p>Out of 584 phaeochromocytoma and paraganglioma resections, 383 operations were performed without α-receptor blockade (including 84 with ß-receptor blockade). Before operation and intraoperatively, patients with ß-receptor blockade presented with higher systolic blood pressure (155 [25] and 207 [62] mm Hg) than patients without ß-receptor blockade (147 [24] and 183 [52] mm Hg; <em>P</em>=0.006 and <em>P</em>=0.001, respectively). Intraoperatively, patients with ß-receptor blockade demonstrated a higher incidence of hypotensive episodes (25% without <em>vs</em> 41% with ß-blockade; <em>P</em>&lt;0.001). After propensity score matching no difference between the groups could be confirmed.</p></div><div><h3>Conclusion</h3><p>Overall, patients with isolated ß-receptor blockade developed higher blood pressure before operation and intraoperatively. After propensity score matching a difference could no longer be detected. Overall, ß-receptor blockade seems to be more a sign for severe disease than a risk factor for haemodynamic instability.</p></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"8 ","pages":"Article 100240"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772609623001193/pdfft?md5=535e16dd7aff33ea71270172098d6c39&pid=1-s2.0-S2772609623001193-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138501543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors and outcomes of perioperative cardiac arrest in children undergoing noncardiac surgery 非心脏手术儿童围手术期心脏骤停的预测因素和结局
Pub Date : 2023-12-01 DOI: 10.1016/j.bjao.2023.100244
Carine Foz, Steven J. Staffa, Morgan L. Brown, James A. DiNardo, Viviane G. Nasr

Background

Perioperative cardiac arrest continues to occur. This study aims to identify risk factors for perioperative cardiac arrest in children presenting for noncardiac surgery and characterise its outcomes.

Methods

Using the National Surgical Quality Improvement Program (NSQIP) Pediatric Database 2019 and 2020, 261 276 patients were included. Patients ≥18 yr and cardiac surgical procedures were excluded. Exploratory multivariable analysis was performed to identify independent predictors of perioperative cardiac arrest and associated outcomes.

Results

The overall rate of cardiac arrest was 0.1%, with an intraoperative rate of 0.05% and 48-h postoperative rate of 0.06%. Significant risk factors for perioperative cardiac arrest included age <12 months (adjusted odds ratios [aOR] 3.07, P<0.001), American Society of Anesthesiology Physical Status classification (ASA-PS 3 aOR=2.57, P<0.001; ASA-PS 4 aOR=5.27, P<0.001; ASA-PS 5 aOR=13.1, P<0.001), admission through the emergency room (aOR 1.7, P=0.003), inpatient (aOR 2.19, P=0.008), major and severe cardiac disease (aOR 1.58, P=0.008), impaired cognitive status (aOR 1.54, P=0.009), and longer anaesthesia duration (aOR 1.1 per 30 min, P<0.001). Perioperative cardiac arrest was significantly associated with longer hospital length of stay, reoperation, differences in discharge destination, and 30-day mortality. In addition, patients experiencing postoperative cardiac arrest had a significantly higher rate of in-hospital and 30-day mortality than those experiencing intraoperative cardiac arrest.

Conclusions

The incidence of cardiac arrest in this study is higher than previously reported. This may be related to selection bias and the rigorous data collection required by NSQIP. Lower 30-day mortality after intraoperative cardiac arrest could be related to prompt recognition and rapid initiation of intraoperative resuscitation. Identification of perioperative risk factors for cardiac arrest is crucial to improve the safety and quality of patient care.

围手术期心脏骤停持续发生。本研究旨在确定非心脏手术患儿围手术期心脏骤停的危险因素,并描述其结果。方法使用国家外科质量改进计划(NSQIP) 2019年和2020年儿科数据库,纳入26276例患者。年龄≥18岁且接受过心脏外科手术的患者被排除在外。进行探索性多变量分析,以确定围手术期心脏骤停和相关结果的独立预测因素。结果全组心脏骤停发生率为0.1%,术中0.05%,术后48 h 0.06%。围手术期心脏骤停的重要危险因素包括年龄和12个月(校正优势比[aOR] 3.07, P<0.001)、美国麻醉学会生理状态分类(asa - ps3 aOR=2.57, P<0.001;asa - ps4 aOR=5.27, P<0.001;asa - ps5 aOR=13.1, P<0.001),通过急诊室入院(aOR为1.7,P=0.003),住院(aOR为2.19,P=0.008),主要和严重心脏病(aOR为1.58,P=0.008),认知状况受损(aOR为1.54,P=0.009),麻醉时间较长(aOR为1.1 / 30 min, P<0.001)。围手术期心脏骤停与住院时间延长、再手术、出院目的地差异和30天死亡率显著相关。此外,术后心脏骤停患者的住院死亡率和30天死亡率明显高于术中心脏骤停患者。结论本研究中心脏骤停的发生率高于先前报道。这可能与选择偏差和NSQIP要求的严格数据收集有关。术中心脏骤停后30天死亡率较低可能与及时识别和快速启动术中复苏有关。识别心脏骤停的围手术期危险因素对提高患者护理的安全性和质量至关重要。
{"title":"Predictors and outcomes of perioperative cardiac arrest in children undergoing noncardiac surgery","authors":"Carine Foz,&nbsp;Steven J. Staffa,&nbsp;Morgan L. Brown,&nbsp;James A. DiNardo,&nbsp;Viviane G. Nasr","doi":"10.1016/j.bjao.2023.100244","DOIUrl":"https://doi.org/10.1016/j.bjao.2023.100244","url":null,"abstract":"<div><h3>Background</h3><p>Perioperative cardiac arrest continues to occur. This study aims to identify risk factors for perioperative cardiac arrest in children presenting for noncardiac surgery and characterise its outcomes.</p></div><div><h3>Methods</h3><p>Using the National Surgical Quality Improvement Program (NSQIP) Pediatric Database 2019 and 2020, 261 276 patients were included. Patients ≥18 yr and cardiac surgical procedures were excluded. Exploratory multivariable analysis was performed to identify independent predictors of perioperative cardiac arrest and associated outcomes.</p></div><div><h3>Results</h3><p>The overall rate of cardiac arrest was 0.1%, with an intraoperative rate of 0.05% and 48-h postoperative rate of 0.06%. Significant risk factors for perioperative cardiac arrest included age &lt;12 months (adjusted odds ratios [aOR] 3.07, <em>P</em>&lt;0.001), American Society of Anesthesiology Physical Status classification (ASA-PS 3 aOR=2.57, <em>P</em>&lt;0.001; ASA-PS 4 aOR=5.27, <em>P</em>&lt;0.001; ASA-PS 5 aOR=13.1, <em>P</em>&lt;0.001), admission through the emergency room (aOR 1.7, <em>P</em>=0.003), inpatient (aOR 2.19, <em>P</em>=0.008), major and severe cardiac disease (aOR 1.58, <em>P</em>=0.008), impaired cognitive status (aOR 1.54, <em>P</em>=0.009), and longer anaesthesia duration (aOR 1.1 per 30 min, <em>P</em>&lt;0.001). Perioperative cardiac arrest was significantly associated with longer hospital length of stay, reoperation, differences in discharge destination, and 30-day mortality. In addition, patients experiencing postoperative cardiac arrest had a significantly higher rate of in-hospital and 30-day mortality than those experiencing intraoperative cardiac arrest.</p></div><div><h3>Conclusions</h3><p>The incidence of cardiac arrest in this study is higher than previously reported. This may be related to selection bias and the rigorous data collection required by NSQIP. Lower 30-day mortality after intraoperative cardiac arrest could be related to prompt recognition and rapid initiation of intraoperative resuscitation. Identification of perioperative risk factors for cardiac arrest is crucial to improve the safety and quality of patient care.</p></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"8 ","pages":"Article 100244"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772609623001235/pdfft?md5=ac658e48a31931f9fa3027147d6cd991&pid=1-s2.0-S2772609623001235-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138473873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regional anaesthesia training in the UK – a national survey 区域麻醉训练在英国-一项全国性调查
Pub Date : 2023-12-01 DOI: 10.1016/j.bjao.2023.100241
Boyne Bellew , David Burkett St-Laurent , Martin Shaw , Toby Ashken , Jonathan Womack , Jonathan Debenham , Michael Getty , Shveta Kajal , Neil Verma , Katie Samuel , Alan J.R. Macfarlane , Rachel J. Kearns , Regional Anaesthesia UK Research Network

Background

Adequate training of anaesthetists in regional anaesthesia is important to ensure optimal patient access to regional anaesthesia.

Methods

We undertook a national survey of UK trainee anaesthetists and Royal College of Anaesthetists (RCoA) tutors to assess experiences of training in regional anaesthesia. We performed descriptive statistics for baseline characteristics, and logistic regression of training indices and tutor confidence that their hospital could provide regional anaesthesia training at all three stages of the RCoA 2021 curriculum.

Results

A total of 492 trainees (19.2%) and 114 tutors (45.2%) completed the survey. Trainees were less likely to have received training in chest/abdominal wall compared with upper/lower limb blocks {erector spinae vs femoral block (odds ratio [OR] 0.25, 95% confidence interval [CI] 0.16–0.39), P<0.001}, or achieved >20 chest/abdominal wall blocks by Stage 3 of training (chest vs lower limb block [OR 0.09, 95% CI 0.05–0.15, P<0.001]. There was a strong association between training received, number of blocks performed (>20 vs 0–5 blocks), and self-reported ability to perform blocks independently, OR 20.9 (95% CI 9.38–53.2). 24/182 (13%) and 10/182 (5.5%) of trainees had performed ≥50 non-obstetric lumbar and thoracic epidurals, respectively, by Stage 3 training. There was a positive association between having a lead clinician for regional anaesthesia, particularly those with paid sessions, and reported confidence to provide regional anaesthesia training at all stages of the curriculum (Stage 3 OR 7.27 [95% CI 2.64–22.0]).

Conclusion

Our results confirm the importance of clinical experience and access to training in regional anaesthesia, and support the introduction of departmental regional anaesthesia leads to improve equity and quality in training opportunities.

背景:对麻醉师进行充分的区域麻醉培训对于确保患者获得最佳的区域麻醉非常重要。方法我们对英国实习麻醉师和皇家麻醉师学院(RCoA)的导师进行了全国性调查,以评估区域麻醉培训的经验。我们对基线特征进行了描述性统计,并对培训指标和导师的信心进行了逻辑回归,他们的医院可以在RCoA 2021课程的所有三个阶段提供区域麻醉培训。结果共有492名学员(19.2%)和114名导师(45.2%)完成调查。与上/下肢阻滞相比,受术者较少接受胸/腹壁训练(竖脊肌与股肌阻滞(比值比[OR] 0.25, 95%可信区间[CI] 0.16-0.39), P<0.001),或在训练的第三阶段达到20例胸/腹壁阻滞(胸部与下肢阻滞[OR 0.09, 95% CI 0.05-0.15, P<0.001]。接受的训练、完成的块数(20 vs 0-5块)和自我报告独立完成块的能力之间有很强的相关性,OR为20.9 (95% CI 9.38-53.2)。在第三阶段训练中,24/182(13%)和10/182(5.5%)的受训者分别进行了≥50次非产科腰椎和胸部硬膜外麻醉。有一名区域麻醉的首席临床医生,特别是那些有付费课程的临床医生,与报告的在课程的所有阶段提供区域麻醉培训的信心之间存在正相关(阶段3 OR 7.27 [95% CI 2.64-22.0])。结论我们的研究结果证实了临床经验和获得区域麻醉培训的重要性,并支持引入科室区域麻醉指导,以提高培训机会的公平性和质量。
{"title":"Regional anaesthesia training in the UK – a national survey","authors":"Boyne Bellew ,&nbsp;David Burkett St-Laurent ,&nbsp;Martin Shaw ,&nbsp;Toby Ashken ,&nbsp;Jonathan Womack ,&nbsp;Jonathan Debenham ,&nbsp;Michael Getty ,&nbsp;Shveta Kajal ,&nbsp;Neil Verma ,&nbsp;Katie Samuel ,&nbsp;Alan J.R. Macfarlane ,&nbsp;Rachel J. Kearns ,&nbsp;Regional Anaesthesia UK Research Network","doi":"10.1016/j.bjao.2023.100241","DOIUrl":"https://doi.org/10.1016/j.bjao.2023.100241","url":null,"abstract":"<div><h3>Background</h3><p>Adequate training of anaesthetists in regional anaesthesia is important to ensure optimal patient access to regional anaesthesia.</p></div><div><h3>Methods</h3><p>We undertook a national survey of UK trainee anaesthetists and Royal College of Anaesthetists (RCoA) tutors to assess experiences of training in regional anaesthesia. We performed descriptive statistics for baseline characteristics, and logistic regression of training indices and tutor confidence that their hospital could provide regional anaesthesia training at all three stages of the RCoA 2021 curriculum.</p></div><div><h3>Results</h3><p>A total of 492 trainees (19.2%) and 114 tutors (45.2%) completed the survey. Trainees were less likely to have received training in chest/abdominal wall compared with upper/lower limb blocks {erector spinae <em>vs</em> femoral block (odds ratio [OR] 0.25, 95% confidence interval [CI] 0.16–0.39), <em>P</em>&lt;0.001}, or achieved &gt;20 chest/abdominal wall blocks by Stage 3 of training (chest <em>vs</em> lower limb block [OR 0.09, 95% CI 0.05–0.15, <em>P</em>&lt;0.001]. There was a strong association between training received, number of blocks performed (&gt;20 <em>vs</em> 0–5 blocks), and self-reported ability to perform blocks independently, OR 20.9 (95% CI 9.38–53.2). 24/182 (13%) and 10/182 (5.5%) of trainees had performed ≥50 non-obstetric lumbar and thoracic epidurals, respectively, by Stage 3 training. There was a positive association between having a lead clinician for regional anaesthesia, particularly those with paid sessions, and reported confidence to provide regional anaesthesia training at all stages of the curriculum (Stage 3 OR 7.27 [95% CI 2.64–22.0]).</p></div><div><h3>Conclusion</h3><p>Our results confirm the importance of clinical experience and access to training in regional anaesthesia, and support the introduction of departmental regional anaesthesia leads to improve equity and quality in training opportunities.</p></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"8 ","pages":"Article 100241"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277260962300120X/pdfft?md5=2f1ffc7b6907927142ffb1cd1d287712&pid=1-s2.0-S277260962300120X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138484125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of acute kidney injury on major adverse cardiovascular events in intensive care survivors 急性肾损伤对重症监护幸存者主要不良心血管事件的影响
Pub Date : 2023-12-01 DOI: 10.1016/j.bjao.2023.100243
Mark Andonovic , Jennifer Curle , Jamie P. Traynor , Martin Shaw , Malcolm A.B. Sim , Patrick B. Mark , Kathryn A. Puxty

Background

Acute kidney injury commonly occurs in patients admitted to ICU. After acute kidney injury, kidney function may not completely recover leading to increased risk of future cardiovascular events. We sought to ascertain the rates of cardiovascular events in ICU survivors and if these rates were affected by the presence of acute kidney injury whilst in ICU.

Methods

This retrospective observational cohort study utilised routinely collected data to identify patients who had survived an admission to one of two ICUs between July 2015 and June 2018. Baseline serum creatinine and subsequent values were used to identify acute kidney injury. Major adverse cardiovascular events described were myocardial injury, coronary artery intervention, or radiological evidence of stroke.

Results

Of the 3994 ICU survivors, major adverse cardiovascular events were identified in 385 patients (9.6%; 95% confidence interval [CI] 8.8–10.6%). Presence of acute kidney injury whilst in ICU was significantly associated with future major adverse cardiovascular events (hazard ratio=1.38; 95% CI 1.12–1.70; P-value=0.003) and future biochemical myocardial injury (hazard ratio=1.48; 95% CI 1.16–1.89; P-value=0.001). Acute kidney injury did not have a statistically significant association with future coronary artery interventions or future cerebrovascular events.

Conclusions

One in 10 ICU survivors experiences a major adverse cardiovascular event after discharge. Acute kidney injury whilst in ICU was associated with an increased risk of major adverse cardiovascular events and specifically myocardial injury. Further research is warranted on whether ICU survivors with acute kidney injury merit enhanced strategies for cardiovascular protection.

背景:急性肾损伤常见于ICU住院患者。急性肾损伤后,肾功能可能不能完全恢复,导致未来心血管事件的风险增加。我们试图确定ICU幸存者心血管事件的发生率,以及这些发生率是否受到ICU急性肾损伤的影响。方法:本回顾性观察性队列研究利用常规收集的数据,确定2015年7月至2018年6月期间入住两个icu之一的患者。基线血清肌酐和随后的值用于识别急性肾损伤。所描述的主要不良心血管事件为心肌损伤、冠状动脉介入或中风的放射证据。结果3994例ICU存活患者中,385例(9.6%;95%置信区间[CI] 8.8-10.6%)。ICU中出现急性肾损伤与未来主要心血管不良事件显著相关(危险比=1.38;95% ci 1.12-1.70;p值=0.003)和未来的生化心肌损伤(风险比=1.48;95% ci 1.16-1.89;假定值= 0.001)。急性肾损伤与未来冠状动脉干预或未来脑血管事件没有统计学上的显著关联。结论1 / 10的ICU幸存者在出院后出现重大心血管不良事件。重症监护病房的急性肾损伤与主要不良心血管事件,特别是心肌损伤的风险增加有关。ICU急性肾损伤幸存者是否值得加强心血管保护策略有待进一步研究。
{"title":"Impact of acute kidney injury on major adverse cardiovascular events in intensive care survivors","authors":"Mark Andonovic ,&nbsp;Jennifer Curle ,&nbsp;Jamie P. Traynor ,&nbsp;Martin Shaw ,&nbsp;Malcolm A.B. Sim ,&nbsp;Patrick B. Mark ,&nbsp;Kathryn A. Puxty","doi":"10.1016/j.bjao.2023.100243","DOIUrl":"https://doi.org/10.1016/j.bjao.2023.100243","url":null,"abstract":"<div><h3>Background</h3><p>Acute kidney injury commonly occurs in patients admitted to ICU. After acute kidney injury, kidney function may not completely recover leading to increased risk of future cardiovascular events. We sought to ascertain the rates of cardiovascular events in ICU survivors and if these rates were affected by the presence of acute kidney injury whilst in ICU.</p></div><div><h3>Methods</h3><p>This retrospective observational cohort study utilised routinely collected data to identify patients who had survived an admission to one of two ICUs between July 2015 and June 2018. Baseline serum creatinine and subsequent values were used to identify acute kidney injury. Major adverse cardiovascular events described were myocardial injury, coronary artery intervention, or radiological evidence of stroke.</p></div><div><h3>Results</h3><p>Of the 3994 ICU survivors, major adverse cardiovascular events were identified in 385 patients (9.6%; 95% confidence interval [CI] 8.8–10.6%). Presence of acute kidney injury whilst in ICU was significantly associated with future major adverse cardiovascular events (hazard ratio=1.38; 95% CI 1.12–1.70; <em>P</em>-value=0.003) and future biochemical myocardial injury (hazard ratio=1.48; 95% CI 1.16–1.89; <em>P</em>-value=0.001). Acute kidney injury did not have a statistically significant association with future coronary artery interventions or future cerebrovascular events.</p></div><div><h3>Conclusions</h3><p>One in 10 ICU survivors experiences a major adverse cardiovascular event after discharge. Acute kidney injury whilst in ICU was associated with an increased risk of major adverse cardiovascular events and specifically myocardial injury. Further research is warranted on whether ICU survivors with acute kidney injury merit enhanced strategies for cardiovascular protection.</p></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"8 ","pages":"Article 100243"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772609623001223/pdfft?md5=865b992741c587d3a5633e3fa1993ebe&pid=1-s2.0-S2772609623001223-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138480726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart rate recovery after orthostatic challenge and cardiopulmonary exercise testing in older individuals: prospective multicentre observational cohort study 老年人站立挑战和心肺运动试验后心率恢复:前瞻性多中心观察队列研究
Pub Date : 2023-11-03 DOI: 10.1016/j.bjao.2023.100238
Aaron James , David Bruce , Nicholas Tetlow , Amour B.U. Patel , Ethel Black , Nicole Whitehead , Anna Ratcliff , Alice Jamie Humphreys , Neil MacDonald , Gayle McDonnell , Ravishankar Raobaikady , Jeeveththaa Thirugnanasambanthar , Jeuela I. Ravindran , Nicole Whitehead , Gary Minto , Tom E.F. Abbott , Shaman Jhanji , Don Milliken , Gareth L. Ackland

Background

Impaired vagal function in older individuals, quantified by the ‘gold standard’ delayed heart rate recovery after maximal exercise (HRRexercise), is an independent predictor of cardiorespiratory capacity and mortality (particularly when HRR ≤12 beats min−1). Heart rate also often declines after orthostatic challenge (HRRorthostatic), but the mechanism remains unclear. We tested whether HRRorthostatic reflects similar vagal autonomic characteristics as HRRexercise.

Methods

Prospective multicentre cohort study of subjects scheduled for cardiopulmonary exercise testing (CPET) as part of routine care. Before undergoing CPET, heart rate was measured with participants seated for 3 min, before standing for 3 min (HRRorthostatic). HRRexercise 1 min after the end of CPET was recorded. The primary outcome was the correlation between mean heart rate change every 10 s for 1 min after peak heart rate was attained on standing and after exercise for each participant. Secondary outcomes were HRRorthostatic and peak VO2 compared between individuals with HRRexercise <12 beats min−1.

Results

A total of 87 participants (mean age: 64 yr [95%CI: 61–66]; 48 (55%) females) completed both tests. Mean heart rate change every 10 s for 1 min after peak heart rate after standing and exercise was significantly correlated (R2=0.81; P<0.0001). HRRorthostatic was unchanged in individuals with HRRexercise ≤12 beats min−1 (n=27), but was lower when HRRexercise >12 beats min−1 (n=60; mean difference: 3 beats min−1 [95% confidence interval 1–5 beats min−1]; P<0.0001). Slower HRRorthostatic was associated with lower peak VO2 (mean difference: 3.7 ml kg-1 min−1 [95% confidence interval 0.7–6.8 ml kg-1 min−1]; P=0.039).

Conclusion

Prognostically significant heart rate recovery after exhaustive exercise is characterised by quantitative differences in heart rate recovery after orthostatic challenge. These data suggest that orthostatic challenge is a valid, simple test indicating vagal impairment.

Clinical trial registration

researchregistry6550.

背景:老年人迷走神经功能受损,通过“黄金标准”最大运动后延迟心率恢复(hrexercise)来量化,是心肺功能和死亡率的独立预测因子(特别是当HRR≤12次min - 1时)。站立挑战(hrreorthostatic)后心率也经常下降,但其机制尚不清楚。我们测试了hrreorthostatic是否反映了与hrexercise相似的迷走神经自主神经特征。方法前瞻性多中心队列研究,受试者计划进行心肺运动试验(CPET)作为常规护理的一部分。在接受CPET之前,参与者坐着3分钟,然后站立3分钟(hrreorthostatic),测量心率。记录CPET结束后1分钟hrexercise情况。主要结果是每位参与者在站立和运动后达到心率峰值后每10秒1分钟的平均心率变化之间的相关性。次要结果是hrreexercise组和hrreexercise组的hrreorthostatic和峰值VO2比较。结果共87例受试者,平均年龄64岁[95%CI: 61 ~ 66];48名(55%)女性完成了两项测试。站立和运动后峰值心率后每10 s平均心率变化1 min显著相关(R2=0.81;术中,0.0001)。hrexercise≤12次/ min - 1时,hrreorthostatic不变(n=27),但当hrexercise≤12次/ min - 1时,hrreorthostatic较低(n=60;平均差值:3次min - 1[95%置信区间1 - 5次min - 1];术中,0.0001)。hrreorthostatic较慢与较低的峰值VO2相关(平均差值:3.7 ml kg-1 min -1[95%置信区间0.7-6.8 ml kg-1 min -1];P = 0.039)。结论穷竭运动后心率恢复具有预后意义,其特征是直立挑战后心率恢复的定量差异。这些数据表明,直立挑战是一个有效的,简单的测试表明迷走神经损伤。临床试验注册:researchregistry6550。
{"title":"Heart rate recovery after orthostatic challenge and cardiopulmonary exercise testing in older individuals: prospective multicentre observational cohort study","authors":"Aaron James ,&nbsp;David Bruce ,&nbsp;Nicholas Tetlow ,&nbsp;Amour B.U. Patel ,&nbsp;Ethel Black ,&nbsp;Nicole Whitehead ,&nbsp;Anna Ratcliff ,&nbsp;Alice Jamie Humphreys ,&nbsp;Neil MacDonald ,&nbsp;Gayle McDonnell ,&nbsp;Ravishankar Raobaikady ,&nbsp;Jeeveththaa Thirugnanasambanthar ,&nbsp;Jeuela I. Ravindran ,&nbsp;Nicole Whitehead ,&nbsp;Gary Minto ,&nbsp;Tom E.F. Abbott ,&nbsp;Shaman Jhanji ,&nbsp;Don Milliken ,&nbsp;Gareth L. Ackland","doi":"10.1016/j.bjao.2023.100238","DOIUrl":"https://doi.org/10.1016/j.bjao.2023.100238","url":null,"abstract":"<div><h3>Background</h3><p>Impaired vagal function in older individuals, quantified by the ‘gold standard’ delayed heart rate recovery after maximal exercise (HRR<sup>exercise</sup>), is an independent predictor of cardiorespiratory capacity and mortality (particularly when HRR ≤12 beats min<sup>−1</sup>). Heart rate also often declines after orthostatic challenge (HRR<sup>orthostatic</sup>), but the mechanism remains unclear. We tested whether HRR<sup>orthostatic</sup> reflects similar vagal autonomic characteristics as HRR<sup>exercise</sup>.</p></div><div><h3>Methods</h3><p>Prospective multicentre cohort study of subjects scheduled for cardiopulmonary exercise testing (CPET) as part of routine care. Before undergoing CPET, heart rate was measured with participants seated for 3 min, before standing for 3 min (HRR<sup>orthostatic</sup>). HRR<sup>exercise</sup> 1 min after the end of CPET was recorded. The primary outcome was the correlation between mean heart rate change every 10 s for 1 min after peak heart rate was attained on standing and after exercise for each participant. Secondary outcomes were HRR<sup>orthostatic</sup> and peak VO<sub>2</sub> compared between individuals with HRR<sup>exercise</sup> &lt;12 beats min<sup>−1</sup>.</p></div><div><h3>Results</h3><p>A total of 87 participants (mean age: 64 yr [95%CI: 61–66]; 48 (55%) females) completed both tests. Mean heart rate change every 10 s for 1 min after peak heart rate after standing and exercise was significantly correlated (<em>R</em><sup>2</sup>=0.81; <em>P</em>&lt;0.0001). HRR<sup>orthostatic</sup> was unchanged in individuals with HRR<sup>exercise</sup> ≤12 beats min<sup>−1</sup> (<em>n</em>=27), but was lower when HRR<sup>exercise</sup> &gt;12 beats min<sup>−1</sup> (<em>n</em>=60; mean difference: 3 beats min<sup>−1</sup> [95% confidence interval 1–5 beats min<sup>−1</sup>]; <em>P</em>&lt;0.0001). Slower HRR<sup>orthostatic</sup> was associated with lower peak VO<sub>2</sub> (mean difference: 3.7 ml kg<sup>-1</sup> min<sup>−1</sup> [95% confidence interval 0.7–6.8 ml kg<sup>-1</sup> min<sup>−1</sup>]; <em>P</em>=0.039).</p></div><div><h3>Conclusion</h3><p>Prognostically significant heart rate recovery after exhaustive exercise is characterised by quantitative differences in heart rate recovery after orthostatic challenge. These data suggest that orthostatic challenge is a valid, simple test indicating vagal impairment.</p></div><div><h3>Clinical trial registration</h3><p>researchregistry6550.</p></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"8 ","pages":"Article 100238"},"PeriodicalIF":0.0,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277260962300117X/pdfft?md5=2e96d909cd26610c248577f0426f6edc&pid=1-s2.0-S277260962300117X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92044487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BJA open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1